<--- Back to Details
First PageDocument Content
Medicine / Pharmacology / Piperidines / Stimulants / Amphetamines / Methylphenidate / Attention deficit hyperactivity disorder / Lisdexamfetamine / Adderall / Psychiatry / Attention-deficit hyperactivity disorder / Nootropics
Date: 2012-10-18 09:10:04
Medicine
Pharmacology
Piperidines
Stimulants
Amphetamines
Methylphenidate
Attention deficit hyperactivity disorder
Lisdexamfetamine
Adderall
Psychiatry
Attention-deficit hyperactivity disorder
Nootropics

Add to Reading List

Source URL: www.cdc.gov

Download Document from Source Website

File Size: 665,85 KB

Share Document on Facebook

Similar Documents

VYVANSE® [Vī’ - văns] MEDICATION GUIDE (lisdexamfetamine dimesylate) CII Capsules What is the most important information I should know about

DocID: 1tcsc - View Document

Amphetamine / Methylphenidate / Attention deficit hyperactivity disorder / Euphoriants / Stimulants / Attention deficit hyperactivity disorder management / Lisdexamfetamine / Dextroamphetamine / Prescription drug / Adult attention deficit hyperactivity disorder / Pemoline / Medical prescription

prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORT

DocID: 1pBj0 - View Document

Amphetamine / Methylphenidate / Attention deficit hyperactivity disorder / Stimulants / Phenethylamines / Attention deficit hyperactivity disorder management / Off-label use / Atomoxetine / Adult attention deficit hyperactivity disorder / Placebo / Pemoline / Lisdexamfetamine

prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management of

DocID: 1ou1z - View Document

Amphetamine / Substituted amphetamines / TAAR1 agonists / Euphoriants / Stimulants / Lisdexamfetamine / Attention deficit hyperactivity disorder management / Dextroamphetamine / Methylphenidate / Attention deficit hyperactivity disorder / Sympathomimetic drug / Psychosis

Microsoft Word - VYVANSE.Product Monographdoc

DocID: 1m5V8 - View Document

Amphetamine / Substituted amphetamines / TAAR1 agonists / Medicine / Nervous system / Chemistry / Lisdexamfetamine / Prodrugs / Shire / Pharmacy / UL

Patient Assistance Program    Shire Pharma Canada ULC (“Shire”) developed the VYVANSE Patient Assistance Program (the “Program”) for Canadian  patients requiring support by covering for t

DocID: 1lpLs - View Document